Breast Lesion Localization Devices market size is USD 315.2 million in 2023

According to Cognitive Market Research, the global Breast Lesion Localization Devices market size is USD 315.2 million in 2023 and will expand at a compound annual growth rate (CAGR) of 6.20% from 2023 to 2030.North America held the major market of more than 40% of the global revenue with a market size of USD 126.08 Million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030Europe held the major market of more than 30% of the global revenue with market size of USD 94.56 Million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.5% from 2023 to 2030Asia Pacific held the major market of more than 23% of the global revenue with market size of USD 72.50 million in 2023 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030Latin America held the major market of more than 5% of the global revenue with market size of USD 15.76 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030Middle East and Africa held the major market of more than 2.00% of the global revenue with market size of USD 14.30 million in 2023 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030 Rising Awareness and Screening Programs to Provide Viable Market OutputThe importance of regular breast cancer screening and early detection is increasingly recognized, leading to a growing demand for breast lesion localization methods. As per the National Cancer Institute (NCI), the most prevalent form of cancer in American women is breast cancer, with an estimated 281,550 new cases expected to be diagnosed in 2023. Early detection through breast cancer screening, including mammography and breast lesion localization, can improve outcomes and reduce mortality rates.For instance, in January 2021, Hologic, Inc. acquired Somatex Medical Technologies for USD 64 million. This acquisition assists the company in providing a broad suite of innovative breast health solutions and expanding its breast marker portfolio with biopsy site markers and localization technologies.Source-www.medicaldevice-network.com/news/hologic-somatex-medical/Growing Geriatric Population and Increase in Breast Cancer Diagnosis to Propel Market GrowthBreast cancer is the most commonly diagnosed cancer among women worldwide, with an estimated 2.3 million new cases diagnosed each year. As the incidence of breast cancer continues to rise, there is a growing need for accurate and efficient methods for lesion localization to enable earlier detection and more effective treatment. Breast cancer is more common among older women, and as the global population ages, the demand for breast lesion localization methods is expected to increase. Market Restraints of the Breast Lesion Localization Devices MarketHigh Cost of Breast Lesion Localization Procedures to Restrict Market GrowthOne of the major restraints in the breast lesion localization methods market is the high cost of the procedures involved. These procedures, which include mammography, MRI, and biopsy, can be costly and may not be covered by insurance in all cases. This can limit the accessibility of breast lesion localization treatment for some patients, particularly in developing countries.Impact of COVID-19 on the Breast Lesion Localization Devices marketThe COVID-19 pandemic severely impacted the market studied, as footfall in hospitals, clinics, and diagnostics centers decreased significantly due to the pandemic-resultant lockdown and the suspension of non-urgent procedures. However, with the released COVID-19 restrictions, reopened oncology care units and hospitals, as well as an increased number of breast cancer surgical procedures and growing awareness programs by the government regarding breast cancer screening and treatment, the studied market is expected to regain its growth over the next 3-4 years. What is Breast Lesion Localization DevicesKey players in the Breast Lesion Localization Devices market employ various strategies to maintain and enhance their market presence. These strategies includes a growing geriatric population and an increase in cancer diagnosis, rising awareness and screening programs, technological advancements, and increasing healthcare expenditure. Additionally, the growing prevalence of breast cancer will drive the demand for breast lesion localization devices in the near future. Breast...